定植抗力抵御艰难梭菌的机制。
Mechanisms of Colonization Resistance Against Clostridioides difficile.
机构信息
Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA.
出版信息
J Infect Dis. 2021 Jun 16;223(12 Suppl 2):S194-S200. doi: 10.1093/infdis/jiaa408.
Abstract
Clostridioides difficile is an urgent antimicrobial-resistant bacterium, causing mild to moderate and sometimes life-threatening disease. Commensal gut microbes are critical for providing colonization resistance against C difficile and can be leveraged as non-antibiotic alternative therapeutics for the prevention and treatment of C difficile infection.
摘要
艰难梭菌是一种紧急的抗微生物药物耐药菌，可导致轻度至中度，有时甚至危及生命的疾病。共生肠道微生物对于提供针对艰难梭菌的定植抵抗至关重要，可作为预防和治疗艰难梭菌感染的非抗生素替代疗法加以利用。
相似文献
1
Mechanisms of Colonization Resistance Against Clostridioides difficile.定植抗力抵御艰难梭菌的机制。
J Infect Dis. 2021 Jun 16;223(12 Suppl 2):S194-S200. doi: 10.1093/infdis/jiaa408.
2
Clearance of Clostridioides difficile Colonization Is Associated with Antibiotic-Specific Bacterial Changes.艰难梭菌定植清除与抗生素特异性细菌变化相关。
mSphere. 2021 May 5;6(3):e01238-20. doi: 10.1128/mSphere.01238-20.
3
Strain-Dependent Inhibition of Clostridioides difficile by Commensal Carrying the Bile Acid-Inducible () Operon.依赖于应变的共生菌携带胆汁酸诱导（）操纵子对艰难梭菌的抑制作用。
J Bacteriol. 2020 May 11;202(11). doi: 10.1128/JB.00039-20.
4
Dietary Xanthan Gum Alters Antibiotic Efficacy against the Murine Gut Microbiota and Attenuates Colonization.饮食性黄原胶改变抗生素对肠道微生物群的疗效并减轻定植。
mSphere. 2020 Jan 8;5(1):e00708-19. doi: 10.1128/mSphere.00708-19.
5
Microbial and metabolic interactions between the gastrointestinal tract and Clostridium difficile infection.肠道微生物与代谢相互作用及其与艰难梭菌感染的关系。
Gut Microbes. 2014 Jan-Feb;5(1):86-95. doi: 10.4161/gmic.27131. Epub 2013 Dec 11.
6
Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids.熊去氧胆酸（UDCA）通过改变肠道胆汁酸减轻艰难梭菌感染期间的宿主炎症反应。
Infect Immun. 2020 May 20;88(6). doi: 10.1128/IAI.00045-20.
7
Clostridioides difficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude competitors from the gut microbiota.艰难梭菌利用毒素介导的炎症来改变宿主的营养状况，并将肠道微生物群中的竞争者排除在外。
Nat Commun. 2021 Jan 19;12(1):462. doi: 10.1038/s41467-020-20746-4.
8
Bile salt metabolism is not the only factor contributing to () disease severity in the murine model of disease.胆汁盐代谢并不是导致疾病严重程度的唯一因素（）在疾病的小鼠模型中。
Gut Microbes. 2020 May 3;11(3):481-496. doi: 10.1080/19490976.2019.1678996. Epub 2019 Dec 2.
9
Gut associated metabolites and their roles in pathogenesis.肠道相关代谢物及其在发病机制中的作用。
Gut Microbes. 2022 Jan-Dec;14(1):2094672. doi: 10.1080/19490976.2022.2094672.
10
Shifts in the Gut Metabolome and Transcriptome throughout Colonization and Infection in a Mouse Model.肠道代谢组和转录组在小鼠模型中的定植和感染过程中的变化。
mSphere. 2018 Mar 28;3(2). doi: 10.1128/mSphere.00089-18. eCollection 2018 Mar-Apr.
引用本文的文献
1
Differential modulation of post-antibiotic colonization resistance to by two probiotic strains.两种益生菌菌株对抗生素后定植抗性的差异调节
mBio. 2025 Jul 21:e0146825. doi: 10.1128/mbio.01468-25.
2
Caffeic acid phenethyl ester protects infection by toxin inhibition and microbiota modulation.咖啡酸苯乙酯通过毒素抑制和微生物群调节来预防感染。
Elife. 2025 Jun 11;13:RP101757. doi: 10.7554/eLife.101757.
3
Dietary Fiber Modulates the Window of Susceptibility to Clostridioides difficile Infection.膳食纤维调节艰难梭菌感染的易感性窗口期。
Gastroenterology. 2025 May 16. doi: 10.1053/j.gastro.2025.04.027.
4
Clostridioides difficile concentration-dependant alterations in gut microbiota of asymptomatic infants.艰难梭菌对无症状婴儿肠道微生物群的浓度依赖性改变
Gut Pathog. 2025 Apr 4;17(1):17. doi: 10.1186/s13099-025-00687-3.
5
Advances in Fecal Microbiota Transplantation for Gut Dysbiosis-Related Diseases.肠道菌群失调相关疾病的粪便微生物群移植研究进展
Adv Sci (Weinh). 2025 Apr;12(13):e2413197. doi: 10.1002/advs.202413197. Epub 2025 Feb 27.
6
Dual RNA-seq study of the dynamics of coding and non-coding RNA expression during infection in a mouse model.在小鼠模型感染过程中编码和非编码RNA表达动态的双RNA测序研究。
mSystems. 2024 Dec 17;9(12):e0086324. doi: 10.1128/msystems.00863-24. Epub 2024 Nov 27.
7
Metagenomic, metabolomic, and lipidomic shifts associated with fecal microbiota transplantation for recurrent infection.与复发性感染的粪便微生物群移植相关的宏基因组、代谢组和脂质组变化。
mSphere. 2024 Oct 29;9(10):e0070624. doi: 10.1128/msphere.00706-24. Epub 2024 Oct 8.
8
Insights into Gut Dysbiosis: Inflammatory Diseases, Obesity, and Restoration Approaches.肠道微生态失调的研究进展：炎症性疾病、肥胖症及相关修复策略
Int J Mol Sci. 2024 Sep 8;25(17):9715. doi: 10.3390/ijms25179715.
9
Bile acids impact the microbiota, host, and dynamics providing insight into mechanisms of efficacy of FMTs and microbiota-focused therapeutics.胆汁酸影响微生物群、宿主和动态，为深入了解 FMT 和专注于微生物组的治疗方法的疗效机制提供了线索。
Gut Microbes. 2024 Jan-Dec;16(1):2393766. doi: 10.1080/19490976.2024.2393766. Epub 2024 Sep 3.
10
Microbiome and Metabolome Restoration After Administration of Fecal Microbiota, Live-jslm (REBYOTA®) for Preventing Recurrent Clostridioides difficile Infection.给予粪便微生物群制剂Live-jslm（REBYOTA®）预防艰难梭菌反复感染后微生物组和代谢组的恢复
J Infect Dis. 2024 Aug 22. doi: 10.1093/infdis/jiae418.
本文引用的文献
1
Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection.系统炎症介质是预测艰难梭菌感染不良结局的有效生物标志物。
mBio. 2020 May 5;11(3):e00180-20. doi: 10.1128/mBio.00180-20.
2
Trends in U.S. Burden of Infection and Outcomes.美国感染负担和结局的趋势。
N Engl J Med. 2020 Apr 2;382(14):1320-1330. doi: 10.1056/NEJMoa1910215.
3
Ursodeoxycholic Acid (UDCA) Mitigates the Host Inflammatory Response during Clostridioides difficile Infection by Altering Gut Bile Acids.熊去氧胆酸（UDCA）通过改变肠道胆汁酸减轻艰难梭菌感染期间的宿主炎症反应。
Infect Immun. 2020 May 20;88(6). doi: 10.1128/IAI.00045-20.
4
Strain-Dependent Inhibition of Clostridioides difficile by Commensal Carrying the Bile Acid-Inducible () Operon.依赖于应变的共生菌携带胆汁酸诱导（）操纵子对艰难梭菌的抑制作用。
J Bacteriol. 2020 May 11;202(11). doi: 10.1128/JB.00039-20.
5
Intestinal bile acids directly modulate the structure and function of TcdB toxin.肠胆酸直接调节 TcdB 毒素的结构和功能。
Proc Natl Acad Sci U S A. 2020 Mar 24;117(12):6792-6800. doi: 10.1073/pnas.1916965117. Epub 2020 Mar 9.
6
Interleukin-22-mediated host glycosylation prevents Clostridioides difficile infection by modulating the metabolic activity of the gut microbiota.白细胞介素-22 介导的宿主糖基化通过调节肠道微生物群的代谢活性来预防艰难梭菌感染。
Nat Med. 2020 Apr;26(4):608-617. doi: 10.1038/s41591-020-0764-0. Epub 2020 Feb 17.
7
A High-Fat/High-Protein, Atkins-Type Diet Exacerbates () Infection in Mice, whereas a High-Carbohydrate Diet Protects.高脂/高蛋白、阿特金斯式饮食会加剧小鼠的（）感染，而高碳水化合物饮食则具有保护作用。 （注：原文括号处内容缺失）
mSystems. 2020 Feb 11;5(1):e00765-19. doi: 10.1128/mSystems.00765-19.
8
Diarrhoeal events can trigger long-term Clostridium difficile colonization with recurrent blooms.腹泻事件可引发艰难梭菌的长期定植，并导致其反复爆发。
Nat Microbiol. 2020 Apr;5(4):642-650. doi: 10.1038/s41564-020-0668-2. Epub 2020 Feb 10.
9
Acetate coordinates neutrophil and ILC3 responses against C. difficile through FFAR2.醋酸盐通过 FFAR2 协调中性粒细胞和 ILC3 对艰难梭菌的反应。
J Exp Med. 2020 Mar 2;217(3). doi: 10.1084/jem.20190489.
10
Safety and Efficacy of Fidaxomicin and Vancomycin in Children and Adolescents with Clostridioides (Clostridium) difficile Infection: A Phase 3, Multicenter, Randomized, Single-blind Clinical Trial (SUNSHINE). fidaxomicin 和万古霉素治疗儿童和青少年艰难梭菌（梭状芽孢杆菌）感染的安全性和疗效：一项 3 期、多中心、随机、单盲临床试验（SUNSHINE）。
Clin Infect Dis. 2020 Dec 17;71(10):2581-2588. doi: 10.1093/cid/ciz1149.
Zotero 插件